- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03751787
Cranial Osteopathy in Functional Disorders of the Newborn
Interest of Treatment With Cranial Osteopathy in Functional Disorders of the Newborn
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Roubaix, France
- Maternité Paul Gelé du CH de Roubaix
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Newborns:
- forward
- born vaginally or cesarean section
- with or without general anesthesia
- with or without epidural or spinal anesthesia
- with or without instrumental extraction
- presenting at least 1 of the 4 criteria detailed above, numbered at 3 or 4 or two criteria at 2
Exclusion Criteria:
Newborns presenting:
- a score of Amiel <7, signing a strong suspicion of non-integrity of brain functions (see table) and therefore leaving the framework of functional pathology
- symptomatic maternal-fetal infection
- true obstetric trauma: brachial plexus paralysis, fracture
- or of a mother who has taken during pregnancy drugs or toxic drugs that affect the behavior of the newborn. (benzodiazepines, subutex, methadone, cocaine, heroin or cannabis)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: cranial osteopathy
The group will receive treatment with osteopathic cranial osteopathy
|
two sessions at three weeks intervals
|
Placebo Comparator: comfort massage
The group will benefit from a placebo manipulation by an osteopathic student who has not yet been trained in cranial osteopathy.
|
manipulation, comfort massage, standardized and not affecting the skull
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Reduction of hyper irritability
Time Frame: at 28 days of life.
|
Reduction of hyper irritability will be done by evaluation from a clinical score,signs of hyper irritability during stay in maternity or postural disorders: one of the following 4 criteria rated 3 or 4, or at least two of these rated criteria 2:
|
at 28 days of life.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Reduction of hyper irritability
Time Frame: before any treatment, at 3 days after deliverance and at 28 days of life
|
Reduction of hyper irritability will be done by evaluation from a clinical score, signs of hyper irritability during stay in maternity or postural disorders: one of the following 4 criteria rated 3 or 4, or at least two of these rated criteria 2:
|
before any treatment, at 3 days after deliverance and at 28 days of life
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Eric Boez, MD, University Hospital, Lille
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2008_43
- 2009-A00037-50 (Other Identifier: ID-RCB number, ANSM)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Newborn Complication
-
Assumpta Solome NantumeDLR German Aerospace Center; Academic Model Providing Access to Healthcare...RecruitingNewborn Morbidity | Newborn ComplicationKenya
-
Universidad Autonoma de Nuevo LeonCompletedHospital Readmission | Newborn Morbidity | Newborn | Newborn Complication
-
Northwell HealthNew York State Department of HealthRecruiting
-
TC Erciyes UniversityCompletedPrevention | Newborn ComplicationTurkey
-
University of Turin, ItalyPall CorporationRecruitingCatheter Complications | Newborn ComplicationItaly
-
Ankara Children's Health and Diseases Hematology...CompletedInfant | Anesthesia Intubation Complication | NewbornTurkey
-
University of California, DavisAdventist Health and RideoutRecruitingMethamphetamine Abuse | Newborn Complication | Patient | NeonatalologyUnited States
-
Neopenda, PBCCenter for Public Health and DevelopmentCompletedNewborn Morbidity | Newborn ComplicationKenya
-
Tania Carbayo JiménezRecruitingIntubation Complication | Cardiopulmonary Resuscitation | Newborn MorbiditySpain
-
Newcastle UniversityCompletedUltrasound | Obstetric Complication | Induction of Labor Affected Fetus / Newborn | Fetal Growth ComplicationsUnited Kingdom
Clinical Trials on cranial osteopathy
-
European School of OsteopathyUnknown
-
Nova Southeastern UniversityOsteopathic Heritage FoundationsCompletedVisual FunctionUnited States
-
Assistance Publique - Hôpitaux de ParisNot yet recruiting
-
Léa GouauxESO Paris Recherche; BTP RMSUnknown
-
Centre Hospitalier René DubosESO Paris RechercheTerminated
-
Ramsay Générale de SantéRecruitingCruciate Ligament Rupture | Knee Ligament Injury | OsteopathiaFrance
-
University Hospital, CaenUnknown
-
Clinique Paris-BercyUnknownIrritable Bowel Syndrome | Ulcerative ColitisFrance
-
Parc de Salut MarUnknown
-
University Hospital, MontpellierCompletedPositilonal Deformation of the Skull | Head Turn Preference | Axial HypertonyFrance